LAVEND Trademark

Trademark Overview

On Tuesday, April 10, 2012, a trademark application was filed for LAVEND with the United States Patent and Trademark Office. The USPTO has given the LAVEND trademark a serial number of 85593584. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2016. This trademark is owned by Glaxo Group Limited. The LAVEND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
lavend

General Information

Serial Number85593584
Word MarkLAVEND
Filing DateTuesday, April 10, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 17, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, June 27, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 27, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 1, 2015EXTENSION 5 GRANTED
Wednesday, July 29, 2015EXTENSION 5 FILED
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2015EXTENSION 4 GRANTED
Monday, March 2, 2015EXTENSION 4 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Thursday, September 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 3, 2014EXTENSION 3 GRANTED
Thursday, August 28, 2014EXTENSION 3 FILED
Thursday, August 28, 2014TEAS EXTENSION RECEIVED
Wednesday, April 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 8, 2014EXTENSION 2 GRANTED
Wednesday, March 12, 2014EXTENSION 2 FILED
Monday, April 7, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 12, 2014TEAS EXTENSION RECEIVED
Friday, September 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2013EXTENSION 1 GRANTED
Wednesday, September 18, 2013EXTENSION 1 FILED
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 2013PUBLISHED FOR OPPOSITION
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 19, 2013TTAB RELEASE CASE TO TRADEMARKS
Tuesday, February 19, 2013OPPOSITION TERMINATED NO. 999999
Tuesday, February 19, 2013OPPOSITION DISMISSED NO. 999999
Friday, February 1, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, December 18, 2012OPPOSITION INSTITUTED NO. 999999
Wednesday, September 19, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 21, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 11, 2012ASSIGNED TO EXAMINER
Tuesday, April 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 13, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

lavend pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological